MedDataX Logo

Online Primary Care Physician (PCP) Training in Screening, Brief Intervention, Referral, and Treatment

NCT ID: NCT01326936

Last Updated: 2012-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project seeks to develop a comprehensive, computer-based education program for primary care physicians that will improve their skills in structured substance abuse screening, brief interventions, and referral and treatment (SBIRT). The investigators will develop two online education programs based on virtual patient (VP) technology. One program will include five typical, interactive, problem-solving VPs and the second will include five identical VPs except that two VPs will have been "worked" by substance abuse experts and presented as case studies. The remaining three VPs will be "unworked" (typical VPs). The investigators hypothesize that both education programs will significantly improve educational outcomes, compared to no training, as measured by a validated survey tool. A secondary hypothesis is that physicians using the "worked" (guided learning) program will achieve similar educational results as those using the typical VP approach, but will require less training time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Education

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Online education Medical education Substance abuse training Drug abuse training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unworked VP

Online education using typical virtual patient (VP) approach. Five unworked VPs presented to subjects for study.

Group Type EXPERIMENTAL

Online education

Intervention Type BEHAVIORAL

A brief (2-hour) interactive online training program in substance abuse (SU) management using virtual patient (VP) technology. Each learner will take one of two similar online programs involving five VPs that represent the range of SU management issues that commonly arise in clinical practice.

Guided Learning

Online education replaces two unworked VPs in Arm 1 with identical worked example VPs (case studies) for learners to study

Group Type EXPERIMENTAL

Online education

Intervention Type BEHAVIORAL

A brief (2-hour) interactive online training program in substance abuse (SU) management using virtual patient (VP) technology. Each learner will take one of two similar online programs involving five VPs that represent the range of SU management issues that commonly arise in clinical practice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online education

A brief (2-hour) interactive online training program in substance abuse (SU) management using virtual patient (VP) technology. Each learner will take one of two similar online programs involving five VPs that represent the range of SU management issues that commonly arise in clinical practice.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physician in primary care training program
* Faculty member in primary care training program

Exclusion Criteria

* Advanced medical training in substance abuse management
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Miami

OTHER

Sponsor Role collaborator

Cleveland Clinic Florida

OTHER

Sponsor Role collaborator

University of Arizona

OTHER

Sponsor Role collaborator

Contra Costa County Regional Medical Center

UNKNOWN

Sponsor Role collaborator

Valley Family Medicine Residency, UC Davis Network

UNKNOWN

Sponsor Role collaborator

Medical Directions, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John M Harris, Jr., MD

Role: PRINCIPAL_INVESTIGATOR

Medical Directions, Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Directions, Inc.

Tucson, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Harris JM Jr, Sun H. The Physicians' Competence in Substance Abuse Test (P-CSAT): a multidimensional educational measurement tool for substance abuse training programs. Drug Alcohol Depend. 2012 May 1;122(3):236-40. doi: 10.1016/j.drugalcdep.2011.10.006. Epub 2011 Nov 4.

Reference Type RESULT
PMID: 22055011 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R44DA026218

Identifier Type: NIH

Identifier Source: org_study_id

View Link